920 results on '"López-Guillermo, Armando"'
Search Results
2. Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma
3. MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms
4. Unraveling the genetics of transformed splenic marginal zone lymphoma
5. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
6. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
7. Genetic and phenotypic attributes of splenic marginal zone lymphoma
8. SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma
9. Follicular lymphoma: An update on diagnosis, prognosis, and management
10. Actualización en el diagnóstico, pronóstico y tratamiento del linfoma folicular
11. Past, present and future of prognostic scores in follicular lymphoma
12. The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma
13. The genomic landscape of transformed splenic diffuse red pulp small B‐cell lymphoma.
14. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes
15. PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax
16. High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era
17. High total metabolic tumor volume at baseline predicts survival independent of response to therapy
18. Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma
19. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma
20. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome
21. HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders
22. Minimal spatial heterogeneity in chronic lymphocytic leukemia at diagnosis
23. RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group
24. Extranodal Localization of Aggressive Lymphoma
25. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy
26. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
27. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
28. Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia
29. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
30. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
31. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
32. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells
33. A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma
34. The academic point‐of‐care anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel (ARI‐0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B‐cell non‐Hodgkin lymphoma
35. Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure
36. A MALT lymphoma prognostic index
37. High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma
38. HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma
39. Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience
40. Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry
41. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia
42. Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage
43. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
44. Genetic evolution in chronic lymphocytic leukaemia
45. Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
46. Extranodal Localization of Aggressive Lymphoma
47. Follicular lymphoma
48. Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome
49. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
50. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.